Email Alert | RSS    帮助

中国防痨杂志 ›› 2014, Vol. 36 ›› Issue (12): 1080-1083.doi: 10.3969/j.issn.1000-6621.2014.12.016

• 论著 • 上一篇    下一篇

62例初治肺结核患者血清纤维化指标监测的临床意义

符立贤 林绍美   

  1. 535300  广西壮族自治区浦北县人民医院感染科
  • 收稿日期:2013-12-09 出版日期:2014-12-10 发布日期:2015-02-28
  • 通信作者: 符立贤 E-mail:flx23597@sina.com

Clinical significance of serum fibrosis index detection in 62 patients with pulmonary tuberculosis

FU Li-xian,LIN Shao-mei   

  1. Infectious Disease Department of Pubei People’s Hospital, Qinzhou of Guangxi Zhuang Autonomous Region, Guangxi, Pubei 535300, China
  • Received:2013-12-09 Online:2014-12-10 Published:2015-02-28
  • Contact: FU Li-xian E-mail:flx23597@sina.com

摘要: 目的 探讨初治肺结核患者血清纤维化指标测定的临床意义。方法 对我院2007年5月至2012年6月感染科住院的62例初治肺结核患者(治疗组)与2010年3月至2012年6月在我院门诊体检合格的62名健康人群(健康对照组)进行血清纤维化指标透明质酸(HA)、层粘连蛋白(LN)、Ⅲ型前胶原肽(PCⅢ)及Ⅳ型胶原C(ⅣC)检测水平的对比;对治疗组进行规范抗结核治疗6个月后,再根据影像学的变化情况是否有效分为治疗有效组与治疗无效组,分别与健康对照组的血清纤维化各项指标进行比较。使用SPSS 13.0软件进行统计学处理,计量资料用“x±s”表示,采用t检验,以P<0.05为差异有统计学意义。 结果 治疗组治疗前血清纤维化指标HA、LN、PCⅢ、ⅣC分别为(131.64±40.92)μg/L、(99.61±42.63)μg/L、(24.30±10.58)μg/L、(60.76±23.15)μg/L,明显高于健康对照组的(58.66±15.42)μg/L、(44.19±10.43)μg/L、(14.32±4.56)μg/L、(39.60±10.30)μg/L,差异均有统计学意义(t值分别为9.3、6.22、5.13、3.9,P值均<0.01)。经过6个月规范化抗结核治疗后,46例治疗有效的患者HA、LN、PCⅢ、ⅣC水平分别为(61.31±19.27)μg/L、(45.62±12.34)μg/L、(13.52±4.83)μg/L、(35.27±16.36)μg/L,与健康对照组[分别为(58.66±15.42)μg/L、(44.19±10.43)μg/L、(14.32±4.56)μg/L、(39.60±10.30)μg/L]比较,差异均无统计学意义(t值分别为2.04、1.83、1.25、-1.07,P值均>0.05);16例治疗无效的患者HA、LN、PCⅢ、ⅣC水平分别为(104.31±18.53)μg/L、(69.94±16.71)μg/L、(13.63±4.07)μg/L、(40.64±9.79)μg/L,与健康对照组比较差异均有统计学意义(t值分别为6.87、5.07、3.75、3.12,P值均<0.05)。结论 血清纤维化指标水平对肺结核的早期纤维化诊断、判断治疗效果和预后有重要的临床价值。

关键词: 复方合剂, 利福平, 药代动力学, 生物利用度, 质谱分析法

Abstract: Objective To explore the clinical significance of serum fibrosis markers detection among new patients with pulmonary tuberculosis(PTB). Methods The radioimmunoassay for detection of serum fibrosis mar-kers, including hyaluronic acid(HA), laminin(LN), type Ⅲ procollagen peptide(PC Ⅲ) and collagen type Ⅳ(C-Ⅳ), were performed among 62 new PTB patients who once stayed at the Infectious Disease Department of our hospital and 62 healthy people who received health check-up at the Outpatient Department of our hospital; the same tests were repeated among 62 PTB patients when they completed the 6 months anti-TB treatment, and those patients were divided into two groups according to their treatment outcomes: effective treatment group and ineffective treatment group. The test results from PTB patients (before and after treatment) and healthy people were compared. SPSS 13.0 software was used for statistical analysis. t test was calculated and P<0.05 was regarded as statistically significant difference. Results The results of HA, LN, PC Ⅲ and C-Ⅳ among PTB patients before treatment were (131.64±40.92)μg/L, (99.61±42.63)μg/L, (24.30±10.58)μg/L and (60.76±23.15)μg/L, which were significantly higher than those indexes among healthy group of people (58.66±15.42)μg/L, (44.19±10.43)μg/L, (14.32±4.56)μg/L, and (39.60±10.30)μg/L)(t=9.3, 6.22, 5.13, 3.9, all P values were <0.01). After received 6 months standard anti-TB treatment, the results of HA, LN, PC Ⅲ and C-Ⅳ among 46 PTB patients who had effective treatment outcomes were (61.31±19.27)μg/L, (45.62±12.34)μg/L, (13.52±4.83)μg/L and (35.27±16.36)μg/L, which had no significant difference compared to those results among the healthy group (t=2.04, 1.83, 1,25 and -1.07; all P value was>0.05). The level of HA, LN, PC Ⅲ and C-Ⅳ among 16 PTB patients who had ineffective treatment outcomes were (104.31±18.53)μg/L, (69.94±16.71)μg/L, (13.63±4.07)μg/L and (40.64±9.79)μg/L, which had significant difference compared to the health group (t=6.87, 5.07, 3.75 and 3.12; all P values were <0.05). Conclusion Detection of serum fibrosis index has important clinical value on early diagnosis of fibrosis among pulmonary tuberculosis patients and prediction of their treatment outcomes.

Key words: Tuberculosis, pulmonary/pathology, Pulmonary fibrosis/blood, Hyaluronic acid, Laminin, Peptide fragments, Procollagen